As mentioned above, lawyers in our Mass Torts Section are currently investigating and filing claims on behalf of individuals who have been diagnosed with bladder cancer following long-term exposure to Actos. Actos is a multi-million dollar diabetes drug manufactured by Takeda, a Japanese pharmaceutical company, with U.S. operations headquartered in Illinois. Actos is currently marketed as a stand-alone drug, Actos, or in combination form, Actoplus Met (Actos plus Metformin), Actoplus Met XR (Actos plus Metformin extended release), and Duetact (Actos plus glimepiride).
Hundreds of Actos lawsuits have been filed in the Actos MDL, which is pending before the Honorable Rebecca Doherty in the Western District of Louisiana. Judge Doherty recently issued a scheduling order setting out litigation deadlines for Plaintiffs and Defendants as well as tentative dates for the start of the first two Actos bladder cancer trials.
If you would like for us to review a potential claim, or if you have any questions regarding the Actos litigation, contact Roger Smith or April Worley in our firm at 800-898-2034 or by email at Roger.Smith@beasleyallen.com or April.Worley@beasleyallen.com.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.